A Two-Year, Three-Arm, Randomized, Double-Masked, Multicentre, Phase III Study Assessing the Efficacy and Safety of Brolucizumab versus Aflibercept in Adult Patients with Visual Impairment due to Diabetic Macular Edema.
Principal Investigator – Prof. Ian McAllister
